In the current study on patients with colorectal cancer who underwent surgical treatment, we elucidated the association of EZH2 expression, gene mutations, or miR-31 expression in the pathway downstream of EGFR with the efficacy of anti-EGFR therapy. Here, EGFR is linked to colorectal cancer.